Physician

Mark Adam Ramirez, MD

According to 2025 Medicare claims, Mark Ramirez, MD (NPI: 1639373210) practices dermatology in the San Angelo, TX market, with the plurality of this provider's patient population coming from Tom Green, TX. This provider's primary affiliated billing organization is WEST TEXAS DERMATOLOGY AND SKIN CANCER CENTER PLLC (NPI: 1942620554; TIN: 464992985) and primary practice location at 76901-9998.

Ramirez's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,090 traditional Medicare patients, billed 9,131 HCPCS/CPT codes, and received $392,637 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,364 prescription claims across 579 beneficiaries totaling $545,269 in drug costs, led by Cosentyx Sensoready (2 Pens) (Secukinumab). Open Payments data shows 4 records totaling $135. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $233,621 to $392,637. Similarly, Part D prescription costs have moved sharply higher in recent years, from $109,197 to $545,269. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$196K$393K2015 Medicare payment: $233,621 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $245,538 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $254,540 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $308,501 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $310,548 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $299,166 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $324,914 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $332,874 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $333,944 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $392,637 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20159165,676$233,621
20168915,700$245,538
20179496,102$254,540
20181,0497,093$308,501
20191,0996,907$310,548
20209826,952$299,166
20211,0077,260$324,914
20221,0737,435$332,874
20231,0938,308$333,944
20241,0909,131$392,637

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$273K$545K2015 Drug cost: $109,197 (USD; Tot_Drug_Cst)2016 Drug cost: $112,472 (USD; Tot_Drug_Cst)2017 Drug cost: $99,895 (USD; Tot_Drug_Cst)2018 Drug cost: $135,676 (USD; Tot_Drug_Cst)2019 Drug cost: $178,673 (USD; Tot_Drug_Cst)2020 Drug cost: $179,463 (USD; Tot_Drug_Cst)2021 Drug cost: $146,914 (USD; Tot_Drug_Cst)2022 Drug cost: $252,018 (USD; Tot_Drug_Cst)2023 Drug cost: $397,496 (USD; Tot_Drug_Cst)2024 Drug cost: $545,269 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015294666$109,197
2016310699$112,472
2017326848$99,895
2018404893$135,676
2019419866$178,673
2020442890$179,463
2021468892$146,914
20225461,144$252,018
20235311,182$397,496
20245791,364$545,269

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more253323$86
11102Biopsy of related skin growth, first growth424525$63
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more715955$60
17000Destruction of precancer skin growth, 1 growth7641,116$36
17003Destruction of precancer skin growth, 2-14 growths6444,263$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Cosentyx Sensoready (2 Pens)Secukinumab19532$161,595
SotyktuDeucravacitinib11330$68,239
FluocinonideFluocinonide992,554$5,398
KetoconazoleKetoconazole2566,679$4,529
Clobetasol PropionateClobetasol Propionate591,628$2,605

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$135GENZYME CORPORATION
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Mark Adam Ramirez, MD?

Tedicare shows public-source Medicare data for Mark Adam Ramirez, MD (NPI 1639373210), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark Adam Ramirez, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mark Adam Ramirez, MD?

Mark Adam Ramirez, MD is linked to WEST TEXAS DERMATOLOGY AND SKIN CANCER CENTER PLLC (billing NPI 1942620554) in the available physician profile data.

Does Mark Adam Ramirez, MD have Open Payments data?

Mark Adam Ramirez, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.